| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.5M | +193.1% |
| R&D Expense | $47.6M | -26.2% |
| SG&A Expense | $36.5M | -12.5% |
| Operating Income | -$42.2M | +52.0% |
| Pre-tax Income | -$46.4M | +48.3% |
| Income Tax | $0 | — |
| Net Income | -$46.4M | +48.3% |
| EPS (Basic) | -$1.23 | +57.7% |
| EPS (Diluted) | -$1.23 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $109.1M | -3.1% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $113.6M | -28.1% |
| Total Assets | $124.8M | -27.0% |
| Current Liabilities | $21.6M | +16.0% |
| Total Liabilities | $48.9M | -41.0% |
| Stockholders' Equity | $75.9M | -14.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.7M | +88.0% |
| Investing Cash Flow | $33.8M | +340.7% |
| Financing Cash Flow | -$29.6M | -135.2% |
| +57.7% |